Pay in 4 interest-free payments of $7.26 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Wang Y, Jiang R
Table 1 Possible association between glucagon-like peptide 1 (GLP-1) and depression based on previous studies
His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc
Primary Analysis CagriSema 2.4mg: 23.0% mean weight loss Zepbound 15mg: 25.5% mean weight loss Treatment Regimen Estimand (Real-World Effectiveness) CagriSema: 20.2% weight loss Zepbound: 23.6% weight loss Because CagriSema did not demonstrate non-inferiority, the trials primary endpoint was not met
US$ 26.53
US$ 23.60
US$ 27.98
US$ 26.16
US$ 20.51
